Acceptance rate 46%
Time to first decision 6 months*
Time to decision with review 50 days*

*Approximate number of days

**The days mentioned above are averages and do not indicate exact durations. The process may vary for each article.


ACTA Pharmaceutica Sciencia 2025 , Vol 63 , Num 2
Abstract PDF Similar Articles Mail to Author
Development and in vitro characterization studies of novel chitosan nanoparticles for the treatment of Huntington's disease
Emre Şefik ÇAĞLAR 1 Emine Büşra EKER FIDAN 2 Mehmet Koray GÖK 2 Neslihan ÜSTÜNDAĞ OKUR 3 Saadet Kevser PABUCCUOĞLU 2 Erdal CEVHER 4
1 University of Health Sciences, Faculty of Pharmacy, Department of Pharmaceutical Biotechnology, Istanbul, Türkiye
2 Istanbul University-Cerrahpasa, Faculty of Engineering, Department of Chemical Engineering, Istanbul, Türkiye
3 University of Health Sciences, Faculty of Pharmacy, Department of Pharmaceutical Technology, Istanbul, Türkiye
4 Istanbul University, Faculty of Pharmacy, Department of Pharmaceutical Technology, Istanbul, Türkiye
DOI : 10.23893/1307-2080.APS6316 Viewed : 114 - Downloaded : 36 Keywords :

Istanbul Medipol University